Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| 260Pt6 | 260Pt6BC | U.S. | 1995 | HIV1 | B | PBMC | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | AZT | NA |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| L210W, T215Y | S68G, D76X, R83K, D123X, T139X, S162C, T200X, V245K |
| >260Pt6BC| codons 37-245 ICTEMEKEGKISKIGPENPYNTPVFAIKKKDGTKWRKLVXFRELNKKTQDFWEVQLGIPH PAGLKKKKSVTVLDVGDAYFSVPLDKXFRKYTAFTIPSINNEXPGIRYQYNVLPQGWKGS PAIFQCSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRXKIEELRQHLWRWGFYT PDKKHQKEPPFLWMGYELHPDKWTVQPIK |
References
| Author | Title | Citation |
| Demeter, LM | Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type I isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). | AAC, 2000 |
| Gonzales, MJ | Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors. | AIDS, 2003 |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |